Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancer discovery"
DOI: 10.1158/2643-3230.bcd-20-0173
Abstract: TET2 is frequently mutated in myeloid neoplasms. Genetic TET2 deficiency leads to skewed myeloid differentiation and clonal expansion, but minimal residual TET activity is critical for survival of neoplastic progenitor and stem cells. Consistent with…
read more here.
Keywords:
myeloid neoplasms;
tet2 mutant;
tet dioxygenase;
tet2 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-3177
Abstract: Clonal hematopoiesis (CH) is common with aging and associated with an increased risk for atherosclerosis (AS) and other cardiovascular diseases (CVD), although molecular mechanisms underlying atherogenesis in CH are only beginning to emerge. TET2 is…
read more here.
Keywords:
hmga1 chromatin;
hmga1;
clonal hematopoiesis;
tet2 mutant ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-5538
Abstract: Progression from chronic phase myeloproliferative neoplasm (MPN) to secondary acute myeloid leukemia (sAML) is a poorly understood, severe complication traditionally linked to additional mutations in the MPN driver clone in genes such as TET2 and…
read more here.
Keywords:
jak2 mutant;
tnf;
jak2;
tet2 mutant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Blood"
DOI: 10.1182/blood.2022015384
Abstract: Gout is a common inflammatory arthritis defined by NLRP3 inflammasome– and IL1β-dependent innate immune responses to monosodium urate (MSU) crystals. Agrawal et al identified clonal hematopoiesis of indeterminate potential (CHIP) as a risk factor for…
read more here.
Keywords:
tet2 mutant;
gout;
risk;
mutant clonal ... See more keywords